Last, we investigate the influence of biologic treatments on the ability to mount effective CD4+ T-cell responses by examining influenza-specific T cells in rheumatoid arthritis (RA) patients before and after vaccination. The gene discussed is CD4; the disease is rheumatoid arthritis.